NANCY ANN DEPARLE - 25 Apr 2022 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Director
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
25 Apr 2022
Net transactions value
$0
Form type
4
Filing time
27 Apr 2022, 18:20:38 UTC
Previous filing
19 Nov 2021
Next filing
13 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Award $0 +902 +4.9% $0.000000 19,483 25 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date.